Low (-4) vs Physiologic (-8) Pressure Digital Continuous Suction After Lung Resection

The goal of this clinical trial is to learn whether using a lower negative pressure (-4 cmH₂O) on a digital chest drainage device after lung resection reduces the time a chest tube must stay in place compared with the commonly used physiologic pressure (-8 cmH₂O), without increasing complications. The trial enrolls adult patients undergoing segmentectomy or lobectomy for lung cancer at a tertiary medical center. The main questions it aims to answer are: Does the -4 cmH₂O setting shorten chest tube duration (primary outcome) compared with -8 cmH₂O? What is the effect of -4 vs -8 cmH₂O on air

Trial Details

NCT ID
NCT07527702
Phase
NA
Sponsor
Seoul National University Hospital
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Low-pressure digital suction (-4 cmH₂O)
Locations (sample)
  • Seoul, South Korea|37.566,126.9784

Key Eligibility Criteria

  • Adults ≥19 years of age.
  • Undergoing anatomical lung resection (segmentectomy or lobectomy) for confirmed or suspected primary lung cancer at a tertiary center.
  • Digital continuous suction device (Thopaz) used as the sole chest drainage system immediately after surgery.
  • Able to provide written informed consent on the day before surgery.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →